Clinical Trial Update: Safety and Efficacy Study of Antioxidants for the Treatment of the Fragile X Syndrome [Phase 2]

View source ↗

Summary

Phase 2 safety and efficacy study of antioxidants for Fragile X syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fragile Syndrome

Drugs mentioned

• antioxidants

Snippet

Sponsor: Yolanda de Diego Otero | Conditions: Fragile X Syndrome | Phase 2 | Status: COMPLETED